Filter search criteria using below inputs
Click on magnifying glass icon to search
Company | Country | Symbol |
---|
Time | Volume | BLUE |
---|---|---|
09:32 ET | 116287 | 6.64 |
09:34 ET | 73675 | 6.68 |
09:36 ET | 28109 | 6.669 |
09:38 ET | 25924 | 6.61 |
09:39 ET | 24417 | 6.6288 |
09:41 ET | 38609 | 6.61 |
09:43 ET | 35011 | 6.6597 |
09:45 ET | 40511 | 6.675 |
09:48 ET | 25295 | 6.63 |
09:50 ET | 12394 | 6.6199 |
09:52 ET | 20775 | 6.635 |
09:54 ET | 21791 | 6.78 |
09:56 ET | 101611 | 6.81 |
09:57 ET | 10711 | 6.71 |
09:59 ET | 17552 | 6.66 |
10:01 ET | 29486 | 6.631 |
10:03 ET | 26833 | 6.645 |
10:06 ET | 18399 | 6.7 |
10:08 ET | 10947 | 6.69 |
10:10 ET | 11399 | 6.661 |
10:12 ET | 13722 | 6.7 |
10:14 ET | 21951 | 6.675 |
10:15 ET | 36791 | 6.705 |
10:17 ET | 12194 | 6.7192 |
10:19 ET | 219614 | 6.71 |
10:21 ET | 17268 | 6.64 |
10:24 ET | 52291 | 6.59 |
10:26 ET | 30333 | 6.5641 |
10:28 ET | 25923 | 6.57 |
10:30 ET | 14115 | 6.58 |
10:32 ET | 34935 | 6.5441 |
10:33 ET | 22957 | 6.5599 |
10:35 ET | 49562 | 6.5398 |
10:37 ET | 15091 | 6.565 |
10:39 ET | 18502 | 6.58 |
10:42 ET | 19173 | 6.6125 |
10:44 ET | 8742 | 6.65 |
10:46 ET | 20397 | 6.635 |
10:48 ET | 7251 | 6.6497 |
10:50 ET | 21928 | 6.65 |
10:51 ET | 43424 | 6.6384 |
10:53 ET | 42532 | 6.62 |
10:55 ET | 45496 | 6.575 |
10:57 ET | 51287 | 6.5585 |
11:00 ET | 12017 | 6.55 |
11:02 ET | 8039 | 6.5699 |
11:04 ET | 17684 | 6.5258 |
11:06 ET | 19491 | 6.555 |
11:08 ET | 7619 | 6.5697 |
11:09 ET | 34714 | 6.555 |
11:11 ET | 13121 | 6.5877 |
11:13 ET | 17284 | 6.585 |
11:15 ET | 19976 | 6.615 |
11:18 ET | 93186 | 6.67 |
11:20 ET | 16670 | 6.655 |
11:22 ET | 16108 | 6.66 |
11:24 ET | 13446 | 6.66 |
11:26 ET | 8299 | 6.685 |
11:27 ET | 25927 | 6.705 |
11:29 ET | 5811 | 6.71 |
11:31 ET | 10000 | 6.725 |
11:33 ET | 17311 | 6.7 |
11:36 ET | 9229 | 6.71 |
11:38 ET | 6626 | 6.695 |
11:40 ET | 36418 | 6.72 |
11:42 ET | 11228 | 6.7 |
11:44 ET | 12155 | 6.7 |
11:45 ET | 16115 | 6.685 |
11:47 ET | 19162 | 6.705 |
11:49 ET | 21821 | 6.69 |
11:51 ET | 7945 | 6.6507 |
11:54 ET | 10737 | 6.66 |
11:56 ET | 7723 | 6.64 |
11:58 ET | 16878 | 6.655 |
12:00 ET | 8400 | 6.7 |
12:02 ET | 14214 | 6.72 |
12:03 ET | 25676 | 6.75 |
12:05 ET | 13360 | 6.7375 |
12:07 ET | 1550 | 6.7446 |
12:09 ET | 10689 | 6.7392 |
12:12 ET | 7623 | 6.75 |
12:14 ET | 19537 | 6.7476 |
12:16 ET | 15989 | 6.77 |
12:18 ET | 11874 | 6.785 |
12:20 ET | 11960 | 6.795 |
12:21 ET | 25579 | 6.7909 |
12:23 ET | 63591 | 6.83 |
12:25 ET | 32713 | 6.83 |
12:27 ET | 16436 | 6.8 |
12:30 ET | 21563 | 6.745 |
12:32 ET | 7073 | 6.75 |
12:34 ET | 7979 | 6.77 |
12:36 ET | 11600 | 6.74 |
12:38 ET | 5792 | 6.755 |
12:39 ET | 10502 | 6.76 |
12:41 ET | 13200 | 6.77 |
12:43 ET | 21300 | 6.73 |
12:45 ET | 13306 | 6.69 |
12:48 ET | 17950 | 6.71 |
12:50 ET | 5977 | 6.7 |
Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
---|---|---|---|
bluebird bio Inc | 457.3M | -0.9x | --- |
BioXcel Therapeutics Inc | 419.8M | -3.7x | --- |
Adagio Therapeutics Inc | 436.8M | -1.2x | --- |
Regencell Bioscience Holdings Ltd | 421.6M | -291.0x | --- |
Aldeyra Therapeutics Inc | 451.4M | -6.6x | --- |
Hillevax Inc | 432.9M | -2.6x | --- |
bluebird bio, Inc. is a biotechnology company. The Company is principally focused on researching, developing and commercializing gene therapies for genetic diseases. The Company’s gene therapy programs in genetic diseases include programs for B-thalassemia; LentiGlobin product candidate as a treatment for sickle cell disease (SCD), and elivaldogene autotemcel (eli-cel) as a treatment for cerebral adrenoleukodystrophy (CALD). It is using a lentiviral vector (LVV) platform, it custom designs each of its therapies to address the underlying cause of disease. The Company is developing lovotibeglogene autotemcel (lovo-cel) as a one-time treatment for patients with SCD, a genetic disease caused by a single mutation in the B-globin gene that leads to the production of abnormal sickle hemoglobin (HbS). The BLA for betibeglogene autotemcel (beti-cel) is for B-thalassemia in patients who receive regular red blood cell (RBC) transfusions.
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $457.3M |
---|---|
Revenue (TTM) | $6.1M |
Shares Outstanding | 77.1M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.36 |
EPS | $-7.05 |
Book Value | $5.26 |
P/E Ratio | -0.9x |
Price/Sales (TTM) | 75.1 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -8,504.88% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.